Lispro
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
85
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Diabetes Mellitus, Type 2
Conditions
Diabetes Mellitus, Type 2
Trial Timeline
Oct 1, 2010 โ Feb 1, 2013
NCT ID
NCT01159938About Lispro
Lispro is a approved stage product being developed by Eli Lilly for Diabetes Mellitus, Type 2. The current trial status is completed. This product is registered under clinical trial identifier NCT01159938. Target conditions include Diabetes Mellitus, Type 2.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02293551 | Phase 1 | Completed |
| NCT01159938 | Approved | Completed |
Competing Products
20 competing products in Diabetes Mellitus, Type 2